The objective of this study was to determine whether nitric oxide (NO) is produced locally in the bovine corpus luteum (CL) and whether NO mediates prostaglandin F 2␣ (PGF 2␣ )-induced regression of the bovine CL in vivo. The local production of NO was determined in early I, early II, mid, late, and regressed stages of CL by determining NADPH-d activity and the presence of inducible and endothelial NO synthase immunolabeling. To determine whether inhibition of NO production counteracts the PGF 2␣ -induced regression of the CL, saline (10 ml/h; n ‫؍‬ 10) or a nonselective NOS inhibitor (N-nitro-L-arginine methyl ester dihydrochloride [L-NAME]; 400 mg/h; n ‫؍‬ 9) was infused for 2 h on Day 15 of the estrous cycle into the aorta abdominalis of Holstein/Polish Black and White heifers. After 30 min of infusion, saline or cloprostenol, an analogue of PGF 2␣ (aPGF 2␣ ; 100 g) was injected into the aorta abdominalis of animals infused with saline or L-NAME. NADPH-diaphorase activity was present in bovine CL, with the highest activity at mid and late luteal stages (P Ͻ 0.05). Inducible and endothelial NO synthases were observed with the strongest immunolabeling in the late CL (P Ͻ 0.05). Injection of aPGF 2␣ increased nitrite/nitrate concentrations (P Ͻ 0.01) and inhibited P 4 secretion (P Ͻ 0.05) in heifers that were infused with saline. Infusion of L-NAME stimulated P 4 secretion (P Ͻ 0.05) and concomitantly inhibited plasma concentrations of nitrite/nitrate (P Ͻ 0.05). Concentrations of P 4 in heifers infused with L-NAME and injected with aPGF 2␣ were higher (P Ͻ 0.05) than in animals injected only with aPGF 2␣ . The PGF 2␣ analogue shortened the cycle length compared with that of saline (17.5 ؎ 0.22 days vs. 21.5 ؎ 0.65 days P Ͻ 0.05). L-NAME blocked the luteolytic action of the aPGF 2␣ (22.6 ؎ 1.07 days vs. 17.5 ؎ 0.22 days, P Ͻ 0.05). These results suggest that NO is produced in the bovine CL. NO inhibits luteal steroidogenesis and it may be one of the components of an autocrine/paracrine luteolytic cascade induced by PGF 2␣ .
INTRODUCTION
Secretion of progesterone (P 4 ) is crucial for determining the duration of the estrous cycle and for achieving a successful pregnancy. The bovine corpus luteum (CL) grows rapidly and regresses within 2 days at the time of luteolysis. The mechanisms that control the development and secretory function of the bovine CL involve many factors produced inside and outside of the CL [1] [2] [3] [4] . Although prostaglandin (PG) F 2␣ released from the uterus has been shown to cause regression of the CL of ruminant species [5] , the neuroendocrine, paracrine, and autocrine mechanisms that regulate luteolysis in the cow are not yet fully understood. Studies examining the direct effects of PGF 2␣ on pure populations of steroidogenic luteal cells [6] [7] [8] [9] show that it does not inhibit basal P 4 production by the large luteal cells and stimulates P 4 production by the small luteal cells and by a mixture of large and small luteal cells [9, 10] . These results led researchers to postulate that some products of nonsteroidogenic cells of the bovine CL may mediate the luteolytic action of PGF 2␣ [4, [11] [12] [13] [14] [15] . The CL is a heterogenous gland and, in addition to steroidogenic luteal cells and endothelial cells, it contains fibroblasts and immune cells [16] . Pate [11, 12] suggested that the immune cells and their secreted products, cytokines, are involved in the process of luteal regression. Thus, at the time of luteolysis, macrophages invade the bovine CL [17] and cytokines, especially tumor necrosis factor-␣ and interferon-␥, participate in the apoptotic events that finally lead to structural luteolysis [18] [19] [20] [21] .
In addition to immune cells and cytokines, endothelial cells and their main secretory product, endothelin-1 (ET-1), may mediate the luteolytic action of PGF 2␣ on bovine steroidogenic luteal cells [13-15, 22, 23] . Other studies suggest that ET-1 may be only one of the essential mediators of luteolysis [24, 25] . We previously suggested that NO is a good candidate to serve as a mediator of PGF 2␣ action during luteolysis in cattle [25, 26] . Nitric oxide (NO) directly inhibits P 4 secretion from bovine luteal cells [27, 28] and augments the action of extragonadal PGF 2␣ on the CL, suggesting that it may be involved in the process of luteolysis [26] . The response of the target tissue (CL) to PGF 2␣ can be modified by local factors that have autocrine or paracrine actions [10] . Finally, the inhibition of ovarian NO production by perfusion of the CL with a nonselective NO synthase (NOS) inhibitor (N-nitro-L-arginine methyl ester dihydrochloride, L-NAME) prolonged the duration of the estrous cycle in heifers [25] . Therefore, one might assume that NO is a component of an autocrine/paracrine cascade in the bovine CL and that it plays an important role in the regulation of functional and structural luteolysis. A number of substances produced locally in the CL, including ET-1, cytokines, and NO may be involved in maintaining an equilibrium between luteal development and regression.
The present study was undertaken to determine whether NO mediates PGF 2␣ -induced regression of the bovine CL in vivo. We also examined whether NO may be produced locally in the bovine CL, as indicated by the presence of NADPH-diaphorase (NADPH-d) activity and distribution of endothelial and inducible NOS isoforms (eNOS and iNOS, respectively) in the CL at different stages of the estrus cycle.
MATERIALS AND METHODS
All animal procedures were approved by the local animal care and use committee (agreement 4/2001/N).
In Vitro Studies
NADPH-d staining and immunocytochemistry for eNOS and iNOS. CL from cyclic crossbred Holstein/Polish Black and White (75%/25%; respectively) heifers (n ϭ 20) were obtained at a local abattoir within 10 min after slaughter. The stages of the estrous cycle were estimated by macroscopic observation of the ovary and uterus, as described by Miyamoto et al. [29] . These observations allowed the classification of the CL into five stages: early I (Days 2-4; n ϭ 4), early II (Days 5-7; n ϭ 4), mid (Days 8-12; n ϭ 4), late (Days 14-17; n ϭ 4), and regressed (Days 19-21; n ϭ 4). Immediately after collection, CL were placed into 4% paraformaldehyde solution (Fluka Chemie; Buchs, Switzerland) in 0.1 M phosphate buffer (PB) for an initial fixation of 2 h (during transport of the tissues from the slaughterhouse to the laboratory). CL were then cut into smaller pieces and fixed in 4% paraformaldehyde for an additional 4 h. Fixed tissues were stored in 18% sucrose (POCH; Gliwice, Poland) in PB with 0.01% sodium azide.
Cryostat sections (8 m) were used for immunocytochemistry and histochemistry as previously described [30] . To demonstrate NADPH-d activity, cryostat sections of CL were incubated at 37-38ЊC in a freshly prepared solution of ␤-NADPH (5 mg/ml; Sigma, St Louis, MO), nitroblue tetrazolium (0.5 mg/ml; Sigma-Aldrich; Steinhem, Germany), and Triton X-100 (5 l/ml; Merck, Darmstadt, Germany) in 0.1 M PB pH 7.4 for l h. Control sections were exposed to the staining solution without NADPH. All CL samples were assayed in the same time course and at least three replicates per animal were examined. The activity of NADPH-d in bovine CL was measured as distribution of formazan deposits (the end product of the histochemical reaction). The observations and photographs were made using a light microscope (Olympus IMT-2; Olympus Optical, Tokyo, Japan).
For immunocytochemistry, consecutive sections were rinsed in 0.05 M Tris-hydroxylmethyl aminomethane (TBS; Sigma), then placed in ethanol in ascending concentrations (50%, 70%, 96% and absolute alcohol). The sections were treated with 1% H 2 O 2 in methanol (Sigma) for 30 min to block endogenous peroxidases and then in 0.75% glycine (Sigma) in TBS for 30 min to block free aldehyde groups. After rinsing in TBS, the sections were incubated overnight with primary antibody against eNOS (diluted 1:50; a mouse monoclonal antibody directed against amino acids 1030-1209 of human eNOS; Transduction Laboratories, Lexington, KY) or iNOS (diluted 1:50; a mouse monoclonal antibody directed against amino acids 961-1144 of mouse macrophage iNOS; Transduction Laboratories) as previously described [30] .
The intensity of histochemical (NADPH-d) and histoimmunological reaction (iNOS, eNOS) in the tissues was estimated by measuring the optical density in a defined area using the PC-IMAGE system (MicroImage; Olympus, Olympus Optical) as described previously [30, 31] .
In Vivo Studies
Normally cycling crossbred Holstein/Polish Black and White (75%/ 25% respectively) heifers (18-20 mo of age and 350-450 kg body weight) were injected i.m. with 500 g of a PGF 2␣ analogue, cloprostenol (aPGF 2␣ ; Bioestrophan, Biowet, Gorzow Wielkopolski, Poland) during the luteal phase to induce luteolysis and estrus. The onset of estrus was taken as Day 0 of the estrous cycle.
For infusion of either saline or L-NAME, a catheter was inserted into the posterior aorta abdominalis through the coccygeal artery, as described previously [32] on Day 14 of the subsequent estrous cycle (Day 0 ϭ estrus). The tip of cannula was positioned in the aorta 60-65 cm anterior to the point of insertion and just cranial to the origin of the ovarian artery and caudal to the renal artery ( Fig. 1 ). This placement allowed infused drugs to be transported by the bloodstream directly into the reproductive tract ( Fig. 1) . A second catheter was inserted into the jugular vein for frequent collection of blood samples.
Experiment 1: Preliminary Study
Eighteen crossbred Holstein/Polish Black and White heifers were used to establish the effective dose of L-NAME (Sigma). On Day 15 of the estrous cycle six animals were infused into the aorta abdominalis for 2 h with 20 ml of saline. Thirty minutes after the beginning of saline infusion, three heifers were injected with 2 ml of saline (n ϭ 3) and three with 100 g of cloprostenol; the dose was based on our previous data [33] . Twelve heifers were infused for 2 h with 50, 100, 200, or 400 mg L-NAME/h (n ϭ 3 per dose) into the abdominal aorta and at 30 min of infusion 100 g of aPGF 2␣ was given. Peripheral blood samples were collected from a jugular vein at 10-min intervals (beginning 1 h before and continuing until 1 h after infusions). After Day 15 of the estrous cycle, blood was collected once daily until Day 22 following the first estrus. The plasma was sepa- * The baselines were defined on the basis of data from the first hour of experiment. The area under the curve was measured using data from the last 3 h of the experimental period (see Fig. 4 , 5 and 6). Means Ϯ SEM. a-c Different subscript letters within a column indicate significant differences (P Ͻ 0.05), as determined by one-way ANOVA followed by the Bonferoni multiple comparison test.
rated by centrifugation (2000 ϫ g; 10 min at 4ЊC) and stored at Ϫ20ЊC until P 4 determinations were made.
Experiment 2: Influence of L-NAME on PGF 2␣ -Induced Luteolysis
To test the hypothesis that inhibition of NO production may counteract the luteolytic action of PGF 2␣ , saline alone (10 ml/h; n ϭ 10 animals) or L-NAME (400 mg/h in 20 ml of saline; n ϭ 9 animals) was infused for 2 h into the aorta abdominalis. Thirty minutes after the beginning of saline or L-NAME infusion, saline (2 ml; n ϭ 8 animals) or aPGF 2␣ (100 g in 2 ml; n ϭ 11 animals) was injected into the aorta abdominalis. Blood samples were collected every 10 min during the experiment. From Day 15 of the estrous cycle, blood was collected once daily until Day 22 after the first estrus. Concentrations of P 4 , 3,14-dihydro,15-keto-prostaglandin F 2␣ (PGFM) and nitrite/nitrate in the plasma samples were measured. All animals were checked for estrus at 12-h intervals after aPGF 2␣ or saline injection.
Hormone Determinations P 4 concentrations in the plasma samples were assayed using a direct enzyme immunoassay (EIA). P 4 labeled by horseradish peroxidase (P 4 -HRP) was used as a tracer. Cross-reactivities of the anti-P 4 serum (donated by Dr. S. Okrasa, University of Warmia and Mazury in Olsztyn, Poland), were determined by comparing the inhibition of binding of P 4 -HRP to antiserum. Results were as follows: 100% with P 4 ; 38.9% with pregnenolone; 11.1% with 17␣-hydroxy-progesterone; 9.8% with 17␤-estradiol; 1.2% with dihydrotestosterone and testosterone; and less than 0.5% with 11-desoxycortisol, estrone, cortisol, and 4-androsten-3,17-dione. In brief, 25-l aliquots of standards or serum samples were incubated in the dark at room temperature for 18-24 h with 100 l of P 4 antiserum (1:100 000 final dilution) and with 100 l of P 4 -HRP (1:150 000 final dilution) in duplicates in 96-well ELISA plates (Corning Inc., Corning, NY) coated with ovine anti-rabbit secondary antibody. After discarding the reagents, the plates were washed three times with 300 l of Tween-80 (0.05%) and 150 l of substrate buffer with 3,3Ј, 5,5Ј tetramethylbenzidine (Sigma) added to each well. The plates were further incubated at 36ЊC for 40 min in the dark. The reaction was stopped by adding 50 l of 2 M H 2 SO 4 to each well. The absorbance was measured at 450 nm with a plate reader (Labsytem, Helsinki, Finland). The P 4 standard curve ranged from 0.39 pg/ml to 25 ng/ml and the effective dose for 50% inhibition (ID50) of the assay was 2.85 ng/ml. The intraassay and interassay coefficients of variation averaged 6.6% and 8.4%, respectively.
The plasma concentrations of PGFM were determined with an EIA as previously described for PGF 2␣ [27] using HRP-labeled PGFM and anti-PGFM serum (WS4468-5; donated by Dr. W.J. Silvia, University of Kentucky, Lexington, KY). Cross-reactivities of the anti-PGFM serum, validated by comparing the inhibition of binding of HRP-labeled PGFM to antiserum, were as follows: PGFM, 100%; PGE 2 , 0%; PGE 1 , 18%; PGA 1 , 10%; PGA 2 , 4.6%; PGB 2 , 6.7%; PGD 2 , 0.13%; PGF 2␣ , 2.8%; PGJ 2 , 14%; and 15-keto PGE 2 , 0.05%. The PGFM standard curve ranged from 32.5 pg/ml to 8000 pg/ml, and the ID50 of the assay was 315 pg/ml. The intraassay and interassay coefficients of variation were on average 7.6% and 10.4%, respectively.
Nitrate/Nitrite Determination in Plasma
Plasma concentrations of nitrite/nitrate, the stable metabolites of NO, were measured by a colorimetric method using the Griess reaction as described by Green et al. [34] . The assay sensitivity was 0.065 g/ml and the standard curve ranged from 0.05 g/ml to 6.9 g/ml. The intraassay and interassay coefficients of variation were on average 8.6% and 15.4%, respectively.
Statistical Analysis
The intensity of NADPH-d activity and histoimmunological reaction, the length of the estrous cycle, and the total amount of released P 4 , PGFM, and stable metabolites of NO (NO 2 Ϫ /NO 3 Ϫ ), represented as the area under the curve (relative units; Table 1 ) were analyzed using ANOVA with the Bonferroni multiple comparison test (ANOVA; GraphPAD PRISM, San Diego, CA). Least squares means and standard errors of the mean were reported. Plasma concentrations of hormones (P 4 , PGFM) and stable metabolites of NO (NO 2 Ϫ /NO 3 Ϫ ) were analyzed using ANOVA with repeated measures (ANOVA; GraphPAD PRISM).
RESULTS

In Vitro Studies: NADPH-d Histochemistry and NOS Immunohistochemistry
Bovine CL showed NADPH-d activity (a marker for NO synthase) in luteal tissue and in blood vessels during the entire estrous cycle (Fig. 2a) . However, the intensity of the histochemical reactions differed among stages of the estrous cycle (Fig. 2d) . The intensity of reaction (arbitrary units, optical density analysis, MicroImage) increased from early I until the late luteal phase of the estrous cycle and than decreased (Fig. 2d) . Figure 2b shows eNOS-like immunoreactivity in the endothelium of blood vessels and in luteal cells. Immunostaining of iNOS was also observed in luteal cells and, in lesser amounts, in the endothelium of blood vessels (Fig. 2c) . Endothelial NOS and iNOS increased greatly in late CL (Fig. 2d ).
Experiment 1: Preliminary Study
There was a dose-dependent effect of L-NAME on aPGF 2␣ -stimulated luteolysis ( Fig. 3 ; P Ͻ 0.05). Injection of aPGF 2␣ shortened the cycle length (17.7 Ϯ 0.3 days) compared with that of a control heifer injected with saline (22.3 Ϯ 0.3 days). Three low doses of L-NAME (50, 100, and 200 mg/h) failed to inhibit regression of the CL induced by injection of aPGF 2␣ (cycle durations of 17.3 Ϯ 0.3, 18.0 Ϯ 0.6, and 18.6 Ϯ 0.9 days, respectively). The luteolytic action of aPGF 2␣ was blocked by 400 mg/h of L-NAME, as shown by the longer cycle duration (23.0 Ϯ 0.9 days). On the basis of this preliminary experiment, the dose of 400 mg/h of L-NAME was chosen for further study.
Experiment 2: Influence of L-NAME on PGF 2␣ -Induced Luteolysis
Administration of 100 g of aPGF 2␣ significantly increased plasma nitrite/nitrate concentrations in heifers infused with saline (P Ͻ 0.05; Fig. 4, Table 1 ). Although aPGF 2␣ temporarily increased P 4 secretion in heifers infused with saline, it was decreased within 60 min after treatment compared with the pretreatment values or with the controls injected and infused with saline ( Fig. 5 ; P Ͻ 0.05). Infusion of L-NAME inhibited plasma concentrations of nitrite/nitrate (P Ͻ 0.05; Fig. 4 ; Table 1 ) and concomitantly stimulated P 4 secretion (P Ͻ 0.001; Fig. 5 ; Table 1 ).
The concentrations of PGFM before treatments were similar in all groups and ranged from 60 to 90 pg/ml (Fig.  6) . Injection of aPGF 2␣ during saline infusion evoked a sharp increase in plasma concentrations of PGFM ( Fig. 6 ; Table 1 ). Infusion of L-NAME temporarily mitigated the stimulatory effect of aPGF 2␣ on PGFM compared with that of the group infused with saline and injected with aPGF 2␣ (P Ͼ 0.05). Treatment of heifers with L-NAME and saline, or saline and saline, had no effect on plasma concentrations of PGFM (P Ͼ 0.05).
The effects of L-NAME and aPGF 2␣ on the concentration of P 4 during the estrous cycle are shown in Figure 7 .
Injection of aPGF 2␣ during saline infusion shortened (17.5 Ϯ 0.22 days; P Ͻ 0.05) the cycle length compared with that of the group infused and injected with saline (21.5 Ϯ 0.65 days). In the group infused with 400 mg/h of L-NAME and injected with aPGF 2␣ , the luteolytic effect of aPGF 2␣ was inhibited compared with that of animals infused with saline and injected with aPGF 2␣ (22.6 Ϯ 0.65 days versus 17.5 Ϯ 0.22 days; P Ͻ 0.01). The length of the cycle in the group infused with 400 mg/h of L-NAME and injected with saline was 21.5 Ϯ 0.85 days. There were no differences in the length of the estrous cycle (P Ͼ 0.05) between animals infused with L-NAME and injected with saline or aPGF 2␣ and heifers treated with saline only.
DISCUSSION
The data obtained in the current study support and extend our previous observations [25] [26] [27] and provide new evidence that NO may be one of the important factors involved in the regulation of luteolysis in cattle. Infusion of L-NAME stimulated P 4 secretion, decreased plasma concentrations of nitrite/nitrate, prevented aPGF 2␣ -induced luteolysis, and extended the functional life of the CL. We recently demonstrated that NO directly inhibits P 4 secretion from bovine luteal cells in vitro [27, 28] . Infusion of L-NAME by a microdialysis system in vivo caused a marked increase in P 4 release at Days 17 and 18 of the cycle and prolonged the functional life of CL to at least 25 days [25] . The direct inhibitory effect of NO on P 4 production in bovine luteal cells [27, 28] , the stimulatory effect of L-NAME on P 4 secretion, and the stimulatory effect of PGF 2␣ on nitrite/nitrate concentrations in conscious heifers all suggest that NO plays an important role as an autocrine/paracrine factor in the regulation of luteal steroidogenesis.
We observed NADPH-d activity in bovine luteal cells and endothelial cells. The most intense staining was observed at the mid and late luteal stages. NADPH-d co-localizes with all known NOS isoforms [35, 36] and serves as a marker for NOS. NOS exists in three major isoforms. One of them, the constitutive-neuronal isoform, has been identified in bovine ovarian nerves [37] . In the rodent and human ovary, NO is produced by the other two isoforms, eNOS and iNOS [38, 39] . Our data demonstrate that eNOS is expressed in bovine luteal cells, as well as in the endothelium of the blood vessels penetrating the CL. The endothelial isoform of NOS was observed with the most intensive immunolabeling in the late luteal phase of the cycle. These observations agree with previous data showing that calcium-dependent eNOS is strongly expressed in ovaries and CL of many species in a stage-dependent manner [39] [40] [41] [42] . Moreover, we showed that iNOS is also expressed in bovine CL, with the highest intensity at the late luteal stage ( Fig. 2c and d) . This reaction was found not only in and around blood vessels, but also in the luteal cells. In contrast to our data, iNOS was observed only in endothelium and around blood vessels in porcine CL [43] [44] [45] . However, in situ hybridization studies localized iNOS to granulosa and luteal cells of rat ovaries [38] . In mouse ovaries, iNOS expression was found in the external layers of CL and strong staining was observed in degenerating CL in nonparenchymal cells in the entire CL [41] .
In most organs, including ovaries, iNOS is strongly expressed in response to an immune stimulus, such as infection or trauma [44, 45] . The physiological relevance of the expression of iNOS in normal ovaries of several species and at all stages of the estrous cycle is unclear [35] . However, the mechanisms that control luteolysis in cattle are described as immune cell-dependent and immune responsedependent processes [19] [20] [21] ; therefore, all these findings provide evidence that luteal cell-derived, vascular endothelium-derived, or immune cell-derived NO (or a combination of these) plays an important role in CL function, especially with regard to regulation of steroidogenesis and PG secretion [25] [26] [27] 35 ].
An inhibitor of NOS, L-NAME, did not affect the viability of cultured midcycle luteal cells [19] , nor were stable metabolites of NO detected in cells undergoing apoptosis after cytokine treatment [19] . However, in several tissues and organs, including the ovary, the expression of iNOS is correlated with cytotoxic/cytostatic events and results in a sustained synthesis of NO, which in turn induces apoptotic cell death [35, 46] . In fact, [Ca 2ϩ ] i -mobilizing agents and cytokines elicit an apoptotic response in the vascular endothelial cells through mechanisms that require NO syn-thesis [47] . We have also found that spermine NONOate (an NO donor) strongly reduces the viability of late luteal cells, whereas L-NAME (an NOS inhibitor) had opposite effects (Korzekwa, Okuda, Jaroszewski, Skarzynski, unpublished data). Therefore, the greater concentrations of both eNOS and iNOS observed in late-stage bovine CL in our study suggest that NO produced by NOS isoforms may be involved in both the structural and functional changes that occur in the CL at the time of luteolysis.
Although injections of PGF 2␣ or its analogues induced several parameters of functional and structural luteolysis [32, 48, 49] , direct exposure of the bovine CL to PGF 2␣ via the microdialysis system stimulated P 4 secretion [28, 50] . These results suggest that PGF 2␣ is most effective as a luteolytic factor when it reaches the CL through blood vessels [51] . Several studies suggest that ET-1 may play a role in PGF 2␣ -induced luteolysis [4, 13-15, 22, 23, 50] . Other studies suggest that ET-1 may not be the only essential mediator of luteolysis in the ewe [24, 25, 52] . Although ET-1 and angiotensin-II are elevated 2 h after PGF 2␣ treatment [4, 51] , the effects of PGF 2␣ action on the bovine CL are observed at 30 min after treatment [32, 49] . Recently, Acosta et al. [23] showed that blood flow within the bovine CL initially increased at 0.5-2 h, decreased at 4 h to the level observed at 0 h, and then decreased to a lower level from 8 h after PGF 2␣ treatment. In our study, the plasma concentrations of nitrite/nitrate were elevated during the first 2 h after aPGF 2␣ injection; after that they slowly decreased, indicating that the first factor released by PGF 2␣ may be NO. NO is a potent vasodilator and increases blood flow. Thus, our findings can explain the recent data of Acosta et al. [23] showing that blood flow in the bovine CL is increased just after PGF 2␣ treatment, not decreased, as is commonly assumed. During the first 2 h of PGF 2␣ action, NO may act directly or via PGE 2 [27] to relax vascular smooth muscle cells and maintain the luteal blood flow required for invasion of immune cells into the CL during luteolysis [17, 20] .
In the ewe, a single injection of ET-1 administered systemically at midcycle increased concentrations of P 4 in plasma 4 h after treatment and then reduced mean concentrations of plasma P 4 for the remainder of the cycle [52] . These findings suggest that ET-1 action during luteolysis may represent an indirect effect mediated by other factors [52] . Therefore, an alternative model of CL regression may include a sharp ET-1 elevation just after PGF 2␣ action and then release of some factors that are directly responsible for the early luteolytic events. ET-1 and NO may interact on several regulatory levels [53, 54] , but the precise relationship between these components is not clear. ET-1 is a potent factor in inducing NO production in bovine [55] and rat endothelial cells [56] . Therefore, it is possible that NO may be released by ET-1 during regression of bovine CL.
It has been demonstrated that exogenous PGF 2␣ stimulates the utero-ovarian release of PGF 2␣ in ewes [57, 58] and cows [32, 59] . In our study, L-NAME inhibited PGF 2␣ luteolytic action in bovine CL. However, it did not influence the PGF 2␣ autoamplification system in the uterus or the ovary. Although aPGF 2␣ evoked a sharp increase in PGFM level in the blood, infusion of L-NAME only temporarily mitigated the stimulatory effect of aPGF 2␣ on PGFM. As mentioned previously, PGF 2␣ did not prove to be directly luteolytic on the luteal cells [7] , or in microdialyzed bovine CL [60] . Therefore, it has been suggested in several studies that PGF 2␣ may play a role as a luteotropic agent in an autocrine/paracrine manner [6, 7, 9, 10]. Our study showed that L-NAME inhibited aPGF 2␣ -induced luteolysis but did not influence the PGF 2␣ autoamplification loop. Thus, a direct luteotropic effect of PGF 2␣ on bovine CL may be observed when luteolytic (vascular, NO-dependent) mechanisms are blocked.
In summary, our previous data showed that NO may directly inhibit P 4 secretion in cattle [27, 28] . The greater effects of PGF 2␣ on luteal cells previously exposed to NO suggests that priming of bovine CL by NO is needed for complete luteal regression [26] . This suggestion is confirmed by data showing that an inhibition of ovarian NO production by perfusion of the CL with an NOS inhibitor prolonged the duration of the estrous cycle [25] . The present results demonstrate that the inhibition of NO production (administration of L-NAME) abolished the luteolytic action of aPGF 2␣ . Moreover, we directly showed that NO may be produced in bovine CL. The highest concentrations of NOS activity are found in CL of the late luteal phase (Days 14-17 of the estrous cycle), before uterine luteolytic PGF 2␣ is released (Days 18-20) [61, 62] . The first subluteolytic pulses of PGF 2␣ , which are responsible for the early luteolytic events, may be observed at 12-24 h before P 4 decline in cows (Days 17-19 of the estrous cycle) [61, 62] . Moreover, peaks of luteal PGF 2␣ and luteolytic leukotrienes (types B and C) have been demonstrated on Day 18 in heifers undergoing spontaneous luteolysis and their frequency increased within the 12-h period during which the onset of P 4 decline occurred [63] . However, there might be no overlap between CL from Days 14-17 (highest concentrations of NOS activity) and Days 18-20 of the estrous cycle, when functional and structural luteolysis occurs. Therefore, a complete explanation of the role of NO in initiation of functional luteolysis and the precise relationship between PGF 2␣ , ET-1, and NO in the process of luteal regression in the bovine CL remains to be determined.
